Mural Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	77.09	115.46	270.85	-	-
Short-Term Investments	-	28.92	-	-	-
Cash & Short-Term Investments	77.09	144.39	270.85	-	-
Cash Growth	-62.34%	-46.69%	-	-	-
Accounts Receivable	-	-	-	2.99	-
Other Receivables	-	0.05	5.55	-	-
Total Trade Receivables	-	0.05	5.55	2.99	-
Other Current Assets	4.46	10.45	1.2	1.83	4.24
Total Current Assets	81.56	152.92	277.34	4.82	4.24
Net Property, Plant & Equipment	6	14.5	24.15	28.93	30.87
Other Long-Term Assets	-	0.01	-	-	-
Total Assets	87.56	169.39	301.75	33.75	35.11
Accounts Payable	3.14	2.06	5.97	2.97	10.59
Accrued Expenses	20.22	18.53	16.95	32.75	16.74
Current Portion of Leases	5.01	5.56	6.1	5.84	5.92
Other Current Liabilities	0.05	0.05	-	-	-
Total Current Liabilities	28.42	26.2	29.02	41.56	33.25
Long-Term Leases	0.17	2.46	8.91	13.54	19.39
Other Long-Term Liabilities	0.19	0.24	-	0.3	0.36
Total Long-Term Liabilities	0.35	2.7	8.91	13.85	19.74
Total Liabilities	28.77	28.89	37.93	55.41	52.99
Common Stock	0.17	0.17	0.17	-	-
Additional Paid-in Capital	299.1	299.68	294.51	-	-
Accumulated Other Comprehensive Income	-	0.02	-	-	-
Retained Earnings	-240.49	-159.37	-30.86	-	-
Shareholders' Equity	58.78	140.5	263.82	-43.31	-17.88
Total Liabilities & Equity	87.56	169.39	301.75	33.75	35.11
Total Debt	5.17	8.02	15.01	19.39	25.31
Net Cash (Debt)	71.92	136.36	255.84	-19.39	-25.31
Net Cash Growth	-47.26%	-46.70%	-	-	-
Net Cash Per Share	4.20	8.04	15.33	-1.16	-
Book Value	58.78	140.5	263.82	-43.31	-17.88
Book Value Per Share	3.43	8.29	15.81	-2.60	-
Tangible Book Value	58.78	140.5	263.82	-43.31	-17.88
Tangible Book Value Per Share	3.43	8.29	15.81	-2.60	-

Updated Aug 4, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q